1 2716 175 YOGA MANAGEMENT OF BREAST CANCER-RELATED LYMPHOEDEMA: A RANDOMISED CONTROLLED PILOT-TRIAL. BACKGROUND: SECONDARY ARM LYMPHOEDEMA CONTINUES TO AFFECT AT LEAST 20% OF WOMEN AFTER TREATMENT FOR BREAST CANCER REQUIRING LIFELONG PROFESSIONAL TREATMENT AND SELF-MANAGEMENT. THE HOLISTIC PRACTICE OF YOGA MAY OFFER BENEFITS AS AN ADJUNCT SELF-MANAGEMENT OPTION. THE AIM OF THIS SMALL PILOT TRIAL WAS TO GAIN PRELIMINARY DATA TO DETERMINE THE EFFECT OF YOGA ON WOMEN WITH STAGE ONE BREAST CANCER-RELATED LYMPHOEDEMA (BCRL). THIS PAPER REPORTS THE RESULTS FOR THE PRIMARY AND SECONDARY OUTCOMES. METHODS: PARTICIPANTS WERE RANDOMISED, AFTER BASELINE TESTING, TO RECEIVE EITHER AN 8-WEEK YOGA INTERVENTION (N = 15), CONSISTING OF A WEEKLY 90-MINUTE TEACHER-LED CLASS AND A 40-MINUTE DAILY SESSION DELIVERED BY DVD, OR TO A USUAL CARE WAIT-LISTED CONTROL GROUP (N = 13). PRIMARY OUTCOME MEASURES WERE: ARM VOLUME OF LYMPHOEDEMA MEASURED BY CIRCUMFERENCE AND EXTRA-CELLULAR FLUID MEASURED BY BIOIMPEDANCE SPECTROSCOPY. SECONDARY OUTCOME MEASURES WERE: TISSUE INDURATION MEASURED BY TONOMETRY; LEVELS OF SENSATIONS, PAIN, FATIGUE, AND THEIR LIMITING EFFECTS ALL MEASURED BY A VISUAL ANALOGUE SCALE (VAS) AND QUALITY OF LIFE BASED ON THE LYMPHOEDEMA QUALITY OF LIFE TOOL (LYMQOL). MEASUREMENTS WERE CONDUCTED AT BASELINE, WEEK 8 (POST-INTERVENTION) AND WEEK 12 (FOUR WEEKS AFTER CESSATION OF THE INTERVENTION). RESULTS: AT WEEK 8, THE INTERVENTION GROUP HAD A GREATER DECREASE IN TISSUE INDURATION OF THE AFFECTED UPPER ARM COMPARED TO THE CONTROL GROUP (P = 0.050), AS WELL AS A GREATER REDUCTION IN THE SYMPTOM SUB-SCALE FOR QOL (P = 0.038). THERE WAS NO DIFFERENCE IN ARM VOLUME OF LYMPHOEDEMA OR EXTRA-CELLULAR FLUID BETWEEN GROUPS AT WEEK 8; HOWEVER, AT WEEK 12, ARM VOLUME INCREASED MORE FOR THE INTERVENTION GROUP THAN THE CONTROL GROUP (P = 0.032). CONCLUSIONS: AN 8-WEEK YOGA INTERVENTION REDUCED TISSUE INDURATION OF THE AFFECTED UPPER ARM AND DECREASED THE QOL SUB-SCALE OF SYMPTOMS. ARM VOLUME OF LYMPHOEDEMA AND EXTRA-CELLULAR FLUID DID NOT INCREASE. THESE BENEFITS DID NOT LAST ON CESSATION OF THE INTERVENTION WHEN ARM VOLUME OF LYMPHOEDEMA INCREASED. FURTHER RESEARCH TRIALS WITH A LONGER DURATION, HIGHER LEVELS OF LYMPHOEDEMA AND LARGER NUMBERS ARE WARRANTED BEFORE DEFINITIVE CONCLUSIONS CAN BE MADE.	2014	
                                                                                                                                                                                          
2 2552  53 YOGA FOR CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY AND FALL RISK: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN) IS A COMMON, DEBILITATING SIDE EFFECT THAT WORSENS QUALITY OF LIFE AND INCREASES THE RISK OF FALLS IN CANCER SURVIVORS. EVIDENCE OF YOGA'S SAFETY AND EFFICACY IN TREATING CIPN IS LACKING. METHODS: IN A RANDOMIZED CONTROLLED STUDY, WE ASSIGNED BREAST AND GYNECOLOGICAL CANCER SURVIVORS WITH PERSISTENT MODERATE-TO-SEVERE CIPN PAIN, NUMBNESS, OR TINGLING WITH A SCORE OF 4 OR GREATER (0-10 NUMERIC RATING SCALE [NRS]) FOR AT LEAST 3 MONTHS AFTER CHEMOTHERAPY TO 8 WEEKS OF USUAL CARE OR YOGA FOCUSED ON BREATHWORK AND MUSCULOSKELETAL CONDITIONING. PRIMARY ENDPOINT WAS TREATMENT ARM DIFFERENCES FOR NRS, AND SECONDARY ENDPOINTS WERE FUNCTIONAL ASSESSMENT OF CANCER THERAPY/GYNECOLOGIC ONCOLOGY GROUP-NEUROTOXICITY SUBSCALE (FACT/GOG-NTX), AND FUNCTIONAL REACH TEST AFTER WEEK 8. WE TESTED TREATMENT ARM DIFFERENCES FOR EACH OUTCOME MEASURE USING LINEAR MIXED MODELS WITH TREATMENT-BY-TIME INTERACTIONS. ALL STATISTICAL TESTS WERE TWO-SIDED. RESULTS: WE RANDOMLY ASSIGNED 41 PARTICIPANTS INTO YOGA (N = 21) OR USUAL CARE (N = 20). AT WEEK 8, MEAN NRS PAIN DECREASED BY 1.95 POINTS (95% CONFIDENCE INTERVAL [CI] = -3.20 TO -0.70) IN YOGA VS 0.65 (95% CI = -1.81 TO 0.51) IN USUAL CARE (P = .14). FACT/GOG-NTX IMPROVED BY 4.25 (95% CI = 2.29 TO 6.20) IN YOGA VS 1.36 (95% CI = -0.47 TO 3.19) IN USUAL CARE (P = .035). FUNCTIONAL REACH, AN OBJECTIVE FUNCTIONAL MEASURE PREDICTING THE RISK OF FALLS, IMPROVED BY 7.14 CM (95% CI = 3.68 TO 10.59) IN YOGA AND DECREASED BY 1.65 CM (95% CI = -5.00 TO 1.72) IN USUAL CARE (P = .001). FOUR GRADE 1 ADVERSE EVENTS WERE OBSERVED IN THE YOGA ARM. CONCLUSION: AMONG BREAST AND GYNECOLOGICAL CANCER SURVIVORS WITH MODERATE-TO-SEVERE CIPN, YOGA WAS SAFE AND SHOWED PROMISING EFFICACY IN IMPROVING CIPN SYMPTOMS.	2020	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
3  428  46 CAN YOGA HAVE ANY EFFECT ON SHOULDER AND ARM PAIN AND QUALITY OF LIFE IN PATIENTS WITH BREAST CANCER? A RANDOMIZED, CONTROLLED, SINGLE-BLIND TRIAL. OBJECTIVE: TO EXAMINE THE EFFECTS OF YOGA ON SHOULDER AND ARM PAIN, QUALITY OF LIFE (QOL), DEPRESSION, AND PHYSICAL PERFORMANCE IN PATIENTS WITH BREAST CANCER. METHODS: THIS PROSPECTIVE, RANDOMIZED STUDY INCLUDED 42 PATIENTS. THE PATIENTS IN GROUP 1 UNDERWENT A 10-WEEK HATHA YOGA EXERCISE PROGRAM. THE PATIENTS IN GROUP 2 WERE INCLUDED IN A 10-WEEK FOLLOW-UP PROGRAM. OUR PRIMARY ENDPOINT WAS ARM AND SHOULDER PAIN INTENSITY. RESULTS: THE GROUP RECEIVING YOGA SHOWED A SIGNIFICANT IMPROVEMENT IN THEIR PAIN SEVERITY FROM BASELINE TO POST-TREATMENT, AND THESE BENEFITS WERE MAINTAINED AT 2.5 MONTHS POST-TREATMENT. WHEN COMPARED TO THE CONTROL GROUP, THERE WERE NO STATISTICALLY SIGNIFICANT DIFFERENCES BETWEEN THE 2 GROUPS WITH RESPECT TO THE PARAMETERS ASSESSED AT THE END OF WEEK 10. CONCLUSION: YOGA WAS AN EFFECTIVE AND SAFE EXERCISE FOR ALLEVIATING SHOULDER AND ARM PAIN, WHICH IS A COMPLICATION WITH A HIGH PREVALENCE IN PATIENTS WITH BREAST CANCER.	2018	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
4 2185  68 THE EFFECTS OF YOGA ON SHOULDER AND SPINAL ACTIONS FOR WOMEN WITH BREAST CANCER-RELATED LYMPHOEDEMA OF THE ARM: A RANDOMISED CONTROLLED PILOT STUDY. BACKGROUND: WE AIMED TO EVALUATE THE EFFECT OF AN 8-WEEK YOGA INTERVENTION ON THE SHOULDER AND SPINAL ACTIONS OF WOMEN WITH BREAST CANCER-RELATED ARM LYMPHOEDEMA. METHOD: A RANDOMISED CONTROLLED PILOT TRIAL. THE INTERVENTION GROUP (N = 12) COMPLETED EIGHT WEEKS OF DAILY YOGA SESSIONS WHILE THE CONTROL GROUP (N = 11) CONTINUED WITH BEST CURRENT CARE INCLUDING INFORMATION ON COMPRESSION SLEEVES, SKIN CARE, RISKS OF TEMPERATURE VARIATIONS AND RECOMMENDED SAFE USE OF AFFECTED ARM. LUMBO-PELVIC POSTURE, RANGE OF MOTION (ROM) IN THE SHOULDER AND SPINE, AND STRENGTH IN SHOULDER AND PECTORAL MAJOR AND MINOR, AND SERRATUS ANTERIOR WERE TAKEN AT BASELINE, WEEK 8 AND AFTER A 4-WEEK FOLLOW-UP. OUTCOME ASSESSORS WERE BLINDED TO ALLOCATION. RESULTS: AT WEEK EIGHT THE INTERVENTION GROUP HAD AN IMPROVEMENT IN LUMBO-PELVIC POSTURE, AS INDICATED BY A REDUCTION IN PELVIC OBLIQUITY COMPARED TO THE CONTROL GROUP (MEAN DIFFERENCE = -8.39 DEGREES , 95 % CI: -15.64 TO -1.13 DEGREES , P = 0.023). A SECONDARY FINDING WAS THAT STRENGTH IN SHOULDER ABDUCTION SIGNIFICANTLY INCREASED FOLLOWING THE YOGA INTERVENTION IN BOTH THE AFFECTED (9.5 KG; CI: 0.34 TO 18.66, P = 0.042) AND NON-AFFECTED ARM (11.58 KG; CI: 0.25 TO 22.91; P = 0.045). THERE WERE NO SIGNIFICANT BETWEEN GROUP CHANGES IN ANY ROM MEASURES AS A RESULT OF THE YOGA INTERVENTION. CONCLUSION: THIS PILOT STUDY DEMONSTRATES THAT PARTICIPATION IN YOGA MAY PROVIDE BENEFITS FOR POSTURE AND STRENGTH IN WOMEN WITH BREAST CANCER RELATED LYMPHOEDEMA. THE IMPROVEMENTS MAY BE ATTRIBUTED TO THE FOCUS OF YOGA ON OVERALL POSTURAL AND FUNCTIONAL MOVEMENT PATTERNS. FURTHER TRIALS WITH LONGER INTERVENTION THAT FOLLOW THIS METHODOLOGY ARE WARRANTED. TRIAL REGISTRATION: THE AUSTRALIAN NEW ZEALAND CLINICAL TRIALS REGISTRY ACTRN12611000202965 .	2016	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
5 1331  42 HOME-BASED YOGA PROGRAM FOR THE PATIENTS SUFFERING FROM MALIGNANT LYMPHOMA DURING CHEMOTHERAPY: A FEASIBILITY STUDY. BACKGROUND: YOGA IS PROVEN BENEFICIAL IN IMPROVING QUALITY OF LIFE AMONG BREAST CANCER SURVIVORS RECEIVING CHEMOTHERAPY, BUT ITS EFFECTIVENESS IN LYMPHOMA PATIENTS NEEDS TO BE EXPLORED. AS CHEMOTHERAPY-INDUCED NEUTROPENIA IS VERY COMMON AMONG LYMPHOMA PATIENTS, THEY ARE MUCH PRONE TO INFECTIONS FROM THE ENVIRONMENT. FURTHERMORE, TRAINED YOGA INSTRUCTORS ARE NOT AVAILABLE IN EVERY SETTING, SO THERE IS A NEED TO DEVELOP HOME-BASED YOGA PROGRAM MODULES FOR LYMPHOMA PATIENTS RECEIVING CHEMOTHERAPY. AIM: THE AIM OF THE STUDY WAS TO EXPLORE THE FEASIBILITY AND SAFETY OF YOGIC EXERCISES AMONG LYMPHOMA PATIENTS DURING CHEMOTHERAPY. SUBJECTS AND METHODS: AN INTERVENTIONAL, SINGLE-ARM PREPOST DESIGN STUDY WAS CONDUCTED AT A TERTIARY HEALTH-CARE CENTER. PATIENTS SUFFERING FROM MALIGNANT LYMPHOMA (18-65 YEARS) WITH EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS FROM 0 TO 2, PLANNED TO RECEIVE CHEMOTHERAPY WERE ADMINISTERED A HOME-BASED YOGA PROGRAM OVER A PERIOD OF 2 MONTHS FROM THE START OF CHEMOTHERAPY. THE PRIMARY OUTCOME VARIABLES WERE RETENTION RATE, ACCEPTANCE RATE, SAFETY, AND ADHERENCE. HEALTH-RELATED QUALITY OF LIFE (HRQOL), FATIGUE LEVEL, OVERALL SLEEP QUALITY, DEPRESSION, ANXIETY LEVEL, AND PAIN WERE ALSO ASSESSED. STATISTICAL ANALYSIS: DESCRIPTIVE STATISTICS WAS USED TO SEE THE FEASIBILITY AND ADHERENCE. THE PAIRED T-TEST WAS USED TO COMPARE VARIOUS PRE AND POSTINTERVENTION OUTCOME MEASURES. RESULTS: FOURTEEN PATIENTS (MEDIAN AGE: 36 YEARS, RANGE13-65 YEARS) OF MALIGNANT LYMPHOMA WERE ENROLLED IN THE STUDY. MALE-TO-FEMALE RATIO WAS 9:5. NON-HODGKIN'S LYMPHOMA PATIENTS CONSTITUTED 64%. THE RECRUITMENT RATE WAS 93%. FAVORABLE RETENTION (100%), ACCEPTABILITY (97%), ADHERENCE (78.6%), AND NO SERIOUS ADVERSE EVENTS FOLLOWING YOGA PRACTICE WERE REPORTED. IMPROVEMENT WAS ALSO FOUND IN HRQOL, FATIGUE, SLEEP, DEPRESSION, AND ANXIETY. HOWEVER, IT NEEDS FURTHER VALIDATION IN A RANDOMIZED STUDY. CONCLUSION: HOME-BASED YOGA PROGRAM IS SAFE AND FEASIBLE AMONG THE PATIENTS SUFFERING FROM MALIGNANT LYMPHOMA RECEIVING CHEMOTHERAPY.	2018	
                                                                                                                                                                                                                                                                                                                             
6 1859  57 RANDOMIZED CONTROLLED PILOT TRIAL OF YOGA IN OVERWEIGHT AND OBESE BREAST CANCER SURVIVORS: EFFECTS ON QUALITY OF LIFE AND ANTHROPOMETRIC MEASURES. PURPOSE: TO OBTAIN ESTIMATES OF TIME TO RECRUIT THE STUDY SAMPLE, RETENTION, FACILITY-BASED CLASS ATTENDANCE AND HOME PRACTICE FOR A STUDY OF YOGA IN BREAST CANCER SURVIVORS, AND ITS EFFICACY ON FATIGUE, QUALITY OF LIFE (QOL), AND WEIGHT CHANGE. METHODS: SIXTY-THREE POST-TREATMENT STAGES 0-III BORDERLINE OVERWEIGHT AND OBESE (BODY MASS INDEX >/= 24 KG/M(2)) BREAST CANCER SURVIVORS WERE RANDOMLY ASSIGNED TO A 6-MONTH, FACILITY- AND HOME-BASED VINIYOGA INTERVENTION (N = 32) OR A WAITLIST CONTROL GROUP (N = 31). THE YOGA GOAL WAS FIVE PRACTICES PER WEEK. PRIMARY OUTCOME MEASURES WERE CHANGES IN QOL, FATIGUE, AND WEIGHT FROM BASELINE TO 6 MONTHS. SECONDARY OUTCOMES INCLUDED CHANGES IN WAIST AND HIP CIRCUMFERENCE. RESULTS: IT TOOK 12 MONTHS TO COMPLETE RECRUITMENT. PARTICIPANTS ATTENDED A MEAN OF 19.6 CLASSES AND PRACTICED AT HOME A MEAN OF 55.8 TIMES DURING THE 6-MONTH PERIOD. AT FOLLOW-UP, 90% OF PARTICIPANTS COMPLETED QUESTIONNAIRES AND 87% COMPLETED ANTHROPOMETRIC MEASUREMENTS. QOL AND FATIGUE IMPROVED TO A GREATER EXTENT AMONG WOMEN IN THE YOGA GROUP RELATIVE TO WOMEN IN THE CONTROL GROUP, ALTHOUGH NO DIFFERENCES WERE STATISTICALLY SIGNIFICANT. WAIST CIRCUMFERENCE DECREASED 3.1 CM (95% CI, -5.7 AND -0.4) MORE AMONG WOMEN IN THE YOGA COMPARED WITH THE CONTROL GROUP, WITH NO DIFFERENCE IN WEIGHT CHANGE. CONCLUSIONS: THIS STUDY PROVIDES IMPORTANT INFORMATION REGARDING RECRUITMENT, RETENTION, AND PRACTICE LEVELS ACHIEVED DURING A 6-MONTH, INTENSIVE YOGA INTERVENTION IN OVERWEIGHT AND OBESE BREAST CANCER SURVIVORS. YOGA MAY HELP DECREASE WAIST CIRCUMFERENCE AND IMPROVE QUALITY OF LIFE; FUTURE STUDIES ARE NEEDED TO CONFIRM THESE RESULTS.	2012	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
7 2117  67 THE EFFECT OF YOGA ON WOMEN WITH SECONDARY ARM LYMPHOEDEMA FROM BREAST CANCER TREATMENT. BACKGROUND: WOMEN WHO DEVELOP SECONDARY ARM LYMPHOEDEMA SUBSEQUENT TO TREATMENT ASSOCIATED WITH BREAST CANCER REQUIRE LIFE-LONG MANAGEMENT FOR A RANGE OF SYMPTOMS INCLUDING ARM SWELLING, HEAVINESS, TIGHTNESS IN THE ARM AND SOMETIMES THE CHEST, UPPER BODY IMPAIRMENT AND CHANGES TO A RANGE OF PARAMETERS RELATING TO QUALITY OF LIFE. WHILE EXERCISE UNDER CONTROLLED CONDITIONS HAS HAD POSITIVE OUTCOMES, THE IMPACT OF YOGA HAS NOT BEEN INVESTIGATED. THE AIM OF THIS STUDY IS TO DETERMINE THE EFFECTIVENESS OF YOGA IN THE PHYSICAL AND PSYCHO-SOCIAL DOMAINS, IN THE HOPE THAT WOMEN CAN BE OFFERED ANOTHER SAFE, HOLISTIC MODALITY TO HELP CONTROL MANY, IF NOT ALL, OF THE EFFECTS OF SECONDARY ARM LYMPHOEDEMA. METHODS AND DESIGN: A RANDOMISED CONTROLLED PILOT TRIAL WILL BE CONDUCTED IN HOBART AND LAUNCESTON WITH A TOTAL OF 40 WOMEN RECEIVING EITHER YOGA INTERVENTION OR CURRENT BEST PRACTICE CARE. INTERVENTION WILL CONSIST OF EIGHT WEEKS OF A WEEKLY TEACHER-LED YOGA CLASS WITH A HOME-BASED DAILY YOGA PRACTICE DELIVERED BY DVD. PRIMARY OUTCOME MEASURES WILL BE THE EFFECTS OF YOGA ON LYMPHOEDEMA AND ITS ASSOCIATED SYMPTOMS AND QUALITY OF LIFE. SECONDARY OUTCOME MEASURES WILL BE RANGE OF MOTION OF THE ARM AND THORACIC SPINE, SHOULDER STRENGTH, AND WEEKLY AND DAILY PHYSICAL ACTIVITY. PRIMARY AND SECONDARY OUTCOMES WILL BE MEASURED AT BASELINE, WEEKS FOUR, EIGHT AND A FOUR WEEK FOLLOW UP AT WEEK TWELVE. RANGE OF MOTION OF THE SPINE, IN A SELF-NOMINATED GROUP, WILL BE MEASURED AT BASELINE, WEEKS EIGHT AND TWELVE. A FURTHER OUTCOME WILL BE THE WOMEN'S PERCEPTIONS OF THE YOGA COLLECTED BY INTERVIEW AT WEEK EIGHT. DISCUSSION: THE RESULTS OF THIS TRIAL WILL PROVIDE INFORMATION ON THE SAFETY AND EFFECTIVENESS OF YOGA FOR WOMEN WITH SECONDARY ARM LYMPHOEDEMA FROM BREAST CANCER TREATMENT. IT WILL ALSO INFORM METHODOLOGY FOR FUTURE, LARGER TRIALS. TRIAL REGISTRATION: ACTRN12611000202965.	2012	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
8 2604  58 YOGA FOR PERSISTENT FATIGUE IN BREAST CANCER SURVIVORS: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: CANCER-RELATED FATIGUE AFFLICTS UP TO 33% OF BREAST CANCER SURVIVORS, YET THERE ARE NO EMPIRICALLY VALIDATED TREATMENTS FOR THIS SYMPTOM. METHODS: THE AUTHORS CONDUCTED A 2-GROUP RANDOMIZED CONTROLLED TRIAL TO DETERMINE THE FEASIBILITY AND EFFICACY OF AN IYENGAR YOGA INTERVENTION FOR BREAST CANCER SURVIVORS WITH PERSISTENT POST-TREATMENT FATIGUE. PARTICIPANTS WERE BREAST CANCER SURVIVORS WHO HAD COMPLETED CANCER TREATMENTS (OTHER THAN ENDOCRINE THERAPY) AT LEAST 6 MONTHS BEFORE ENROLLMENT, REPORTED SIGNIFICANT CANCER-RELATED FATIGUE, AND HAD NO OTHER MEDICAL CONDITIONS THAT WOULD ACCOUNT FOR FATIGUE SYMPTOMS OR INTERFERE WITH YOGA PRACTICE. BLOCK RANDOMIZATION WAS USED TO ASSIGN PARTICIPANTS TO A 12-WEEK, IYENGAR-BASED YOGA INTERVENTION OR TO 12 WEEKS OF HEALTH EDUCATION (CONTROL). THE PRIMARY OUTCOME WAS CHANGE IN FATIGUE MEASURED AT BASELINE, IMMEDIATELY POST-TREATMENT, AND 3 MONTHS AFTER TREATMENT COMPLETION. ADDITIONAL OUTCOMES INCLUDED CHANGES IN VIGOR, DEPRESSIVE SYMPTOMS, SLEEP, PERCEIVED STRESS, AND PHYSICAL PERFORMANCE. INTENT-TO-TREAT ANALYSES WERE CONDUCTED WITH ALL RANDOMIZED PARTICIPANTS USING LINEAR MIXED MODELS. RESULTS: THIRTY-ONE WOMEN WERE RANDOMLY ASSIGNED TO YOGA (N = 16) OR HEALTH EDUCATION (N = 15). FATIGUE SEVERITY DECLINED SIGNIFICANTLY FROM BASELINE TO POST-TREATMENT AND OVER A 3-MONTH FOLLOW-UP IN THE YOGA GROUP RELATIVE TO CONTROLS (P = .032). IN ADDITION, THE YOGA GROUP HAD SIGNIFICANT INCREASES IN VIGOR RELATIVE TO CONTROLS (P = .011). BOTH GROUPS HAD POSITIVE CHANGES IN DEPRESSIVE SYMPTOMS AND PERCEIVED STRESS (P < .05). NO SIGNIFICANT CHANGES IN SLEEP OR PHYSICAL PERFORMANCE WERE OBSERVED. CONCLUSIONS: A TARGETED YOGA INTERVENTION LED TO SIGNIFICANT IMPROVEMENTS IN FATIGUE AND VIGOR AMONG BREAST CANCER SURVIVORS WITH PERSISTENT FATIGUE SYMPTOMS.	2012	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
9 2157  43 THE EFFECTS OF UPPER LIMB EXERCISE THROUGH YOGA ON LIMB SWELLING IN CHINESE BREAST CANCER SURVIVORS - A PILOT STUDY. PURPOSE: BREAST CANCER IS THE MOST COMMON FEMALE CANCER. THE AIM OF THIS STUDY WAS TO ASSESS THE IMPACT OF YOGA ON LYMPHEDEMA IN BREAST CANCER SURVIVORS. DESIGN: REPEATED MEASURES BEFORE AND AFTER THE INTERVENTION. WE ENROLLED 15 WOMEN WITH BREAST CANCER WHO HAD NOT PREVIOUSLY WORN ELASTIC CLOTHING TO TREAT LYMPHEDEMA. METHODS: THE PROGRAM WAS LED BY A CERTIFIED TRAINER AND CONSISTED OF 60-MINUTE SESSIONS, THREE TIMES A WEEK FOR 12 WEEKS. THE VOLUMES OF THE AFFECTED AND NORMAL LIMBS WERE MEASURED. A SELF-ASSESSED EDEMA SCORE WAS ALSO RECORDED. FINDINGS: FIFTEEN PATIENTS COMPLETED THE PROGRAM, NONE OF WHOM SUFFERED FROM COMPLICATIONS RELATED TO EXERCISE. THERE WAS NO SIGNIFICANT EDEMA AFTER EXERCISE. NO SIGNIFICANT DIFFERENCES WERE NOTED IN SUBGROUP ANALYSIS BY AGE OR THE AFFECTED ARM. CONCLUSIONS: YOGA DOES NOT INDUCE LYMPHEDEMA. CLINICAL RELEVANCE: LYMPHEDEMA IS USUALLY TREATED WITH UNCOMFORTABLE ELASTIC CLOTHING, AND HIGH-RESISTANCE EXERCISE MAY INDUCE EDEMA. YOGA MAY BE SUITABLE FOR THESE PATIENTS.	2017	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
10 1087  54 EFFECTS OF YOGA ON SYMPTOM MANAGEMENT IN BREAST CANCER PATIENTS: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: THIS STUDY COMPARES THE EFFECTS OF AN INTEGRATED YOGA PROGRAM WITH BRIEF SUPPORTIVE THERAPY ON DISTRESSFUL SYMPTOMS IN BREAST CANCER OUTPATIENTS UNDERGOING ADJUVANT RADIOTHERAPY. MATERIALS AND METHODS: EIGHTY-EIGHT STAGE II AND III BREAST CANCER OUTPATIENTS WERE RANDOMLY ASSIGNED TO RECEIVE YOGA (N = 44) OR BRIEF SUPPORTIVE THERAPY (N = 44) PRIOR TO THEIR RADIOTHERAPY TREATMENT. INTERVENTION CONSISTED OF YOGA SESSIONS LASTING 60 MIN DAILY WHILE THE CONTROL GROUP WAS IMPARTED SUPPORTIVE THERAPY ONCE IN 10 DAYS DURING THE COURSE OF THEIR ADJUVANT RADIOTHERAPY. ASSESSMENTS INCLUDED ROTTERDAM SYMPTOM CHECK LIST AND EUROPEAN ORGANIZATION FOR RESEARCH IN THE TREATMENT OF CANCER-QUALITY OF LIFE (EORTC QOL C30) SYMPTOM SCALE. ASSESSMENTS WERE DONE AT BASELINE AND AFTER 6 WEEKS OF RADIOTHERAPY TREATMENT. RESULTS: A GLM REPEATED-MEASURES ANOVA SHOWED A SIGNIFICANT DECREASE IN PSYCHOLOGICAL DISTRESS (P = 0.01), FATIGUE (P = 0.007), INSOMNIA (P = 0.001), AND APPETITE LOSS (P = 0.002) OVER TIME IN THE YOGA GROUP AS COMPARED TO CONTROLS. THERE WAS SIGNIFICANT IMPROVEMENT IN THE ACTIVITY LEVEL (P = 0.02) IN THE YOGA GROUP AS COMPARED TO CONTROLS. THERE WAS A SIGNIFICANT POSITIVE CORRELATION BETWEEN PHYSICAL AND PSYCHOLOGICAL DISTRESS AND FATIGUE, NAUSEA AND VOMITING, PAIN, DYSPNEA, INSOMNIA, APPETITE LOSS, AND CONSTIPATION. THERE WAS A SIGNIFICANT NEGATIVE CORRELATION BETWEEN THE ACTIVITY LEVEL AND FATIGUE, NAUSEA AND VOMITING, PAIN, DYSPNEA, INSOMNIA, AND APPETITE LOSS. CONCLUSION: THE RESULTS SUGGEST BENEFICIAL EFFECTS WITH YOGA INTERVENTION IN MANAGING CANCER-AND TREATMENT-RELATED SYMPTOMS IN BREAST CANCER PATIENTS.	2009	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
11  162  59 A RANDOMISED CONTROLLED TRIAL OF YOGA FOR THE TREATMENT OF CHRONIC LOW BACK PAIN: RESULTS OF A PILOT STUDY. OBJECTIVE: TO CONDUCT A PILOT TRIAL OF YOGA FOR THE TREATMENT OF CHRONIC LOW BACK PAIN (LBP) TO INFORM THE FEASIBILITY AND PRACTICALITY OF CONDUCTING A FULL-SCALE TRIAL IN THE UK; AND TO ASSESS THE EFFICACY OF YOGA FOR THE TREATMENT OF CHRONIC LOW BACK PAIN. DESIGN: A PRAGMATIC RANDOMISED CONTROLLED TRIAL WAS UNDERTAKEN COMPARING YOGA TO USUAL CARE. PARTICIPANTS: TWENTY PARTICIPANTS WHO HAD PRESENTED TO THEIR GP WITH CHRONIC LOW BACK PAIN IN THE PREVIOUS 18 MONTHS WERE RECRUITED VIA GP RECORDS FROM ONE PRACTICE IN YORK, UK. INTERVENTIONS: TWENTY PATIENTS WERE RANDOMISED TO EITHER 12 WEEKLY 75-MIN SESSIONS OF SPECIALISED YOGA PLUS WRITTEN ADVICE, OR USUAL CARE PLUS WRITTEN ADVICE. ALLOCATION WAS 50/50. MAIN OUTCOME MEASURES: RECRUITMENT RATE, LEVELS OF INTERVENTION ATTENDANCE, AND LOSS TO FOLLOW-UP WERE THE MAIN NON-CLINICAL OUTCOMES. CHANGE AS MEASURED BY THE ROLAND AND MORRIS DISABILITY QUESTIONNAIRE WAS THE PRIMARY CLINICAL OUTCOME. CHANGES IN THE ABERDEEN BACK PAIN SCALE, SF-12, EQ-5D, AND PAIN SELF-EFFICACY WERE SECONDARY CLINICAL OUTCOMES. DATA WERE COLLECTED VIA POSTAL QUESTIONNAIRE AT BASELINE, 4 WEEKS, AND 12 WEEKS FOLLOW-UP. RESULTS: OF THE 286 PATIENTS IDENTIFIED FROM THE GP DATABASE, 52 (18%) CONSENTED AND RETURNED THE ELIGIBILITY QUESTIONNAIRE, OUT OF THESE 20 (6.9%) WERE ELIGIBLE AND RANDOMISED. THE TOTAL PERCENTAGE OF PATIENTS RANDOMISED FROM THE GP PRACTICE POPULATION WAS 0.28%. TEN PATIENTS WERE RANDOMISED TO YOGA, RECEIVING AN AVERAGE OF 1.7 SESSIONS (RANGE 0-5), AND 10 WERE RANDOMISED TO USUAL CARE. AT 12 WEEKS FOLLOW-UP DATA WAS RECEIVED FROM 60% OF PATIENTS IN THE YOGA GROUP AND 90% OF PATIENTS IN THE USUAL CARE GROUP (75% OVERALL). NO SIGNIFICANT DIFFERENCES WERE SEEN BETWEEN GROUPS IN CLINICAL OUTCOMES APART FROM ON THE ABERDEEN BACK PAIN SCALE AT FOUR WEEKS FOLLOW-UP WHERE THE YOGA GROUP REPORTED SIGNIFICANTLY LESS PAIN. CONCLUSION: THIS PILOT STUDY PROVIDED USEFUL DATA AND INFORMATION TO INFORM THE DESIGN AND DEVELOPMENT OF A FULL-SCALE TRIAL OF YOGA FOR CLBP IN THE UK. A KEY FINDING IS THE CALCULATION OF GP PRACTICE TOTAL LIST SIZE REQUIRED FOR PATIENT RECRUITMENT IN A FULL-SCALE TRIAL, AND THE NEED TO IMPLEMENT METHODS TO INCREASE CLASS ATTENDANCE.	2010	
                                                                                                                                                                          
12 2549  58 YOGA FOR CANCER SURVIVORS WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY: HEALTH-RELATED QUALITY OF LIFE OUTCOMES. BACKGROUND: YOGA IS A MEDITATIVE MOVEMENT THERAPY FOCUSED ON MIND-BODY AWARENESS. THE IMPACT OF YOGA ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) OUTCOMES IN PATIENTS WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN) IS UNCLEAR. METHODS: WE CONDUCTED A PILOT RANDOMIZED WAIT-LIST CONTROLLED TRIAL OF 8 WEEKS OF YOGA (N = 21) VERSUS WAIT-LIST CONTROL (N = 20) FOR CIPN IN 41 BREAST AND GYNECOLOGICAL CANCER SURVIVORS WITH PERSISTENT MODERATE TO SEVERE CIPN. HRQOL ENDPOINTS WERE HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS), BRIEF FATIGUE INVENTORY (BFI), AND INSOMNIA SEVERITY INDEX (ISI). THE TREATMENT EXPECTANCY SCALE (TES) WAS ADMINISTERED AT BASELINE. WE ESTIMATED MEAN CHANGES AND 95% CONFIDENCE INTERVALS (CIS) FROM BASELINE TO WEEKS 8 AND 12 AND COMPARED ARMS USING CONSTRAINED LINEAR MIXED MODELS. RESULTS: AT WEEK 8, HADS ANXIETY SCORES DECREASED -1.61 (-2.75, -0.46) IN THE YOGA ARM AND -0.32 (-1.38, 0.75) POINTS IN THE WAIT-LIST CONTROL ARM (P = 0.099). AT WEEK 12, HADS ANXIETY SCORES DECREASED -1.42 (-2.57, -0.28) IN YOGA COMPARED TO AN INCREASE OF 0.46 (-0.60, 1.53) IN WAIT-LIST CONTROL (P = 0.017). THERE WERE NO SIGNIFICANT DIFFERENCES IN HADS DEPRESSION, BFI, OR ISI SCORES BETWEEN YOGA AND WAIT-LIST CONTROL. BASELINE TES WAS SIGNIFICANTLY HIGHER IN YOGA THAN IN WAIT-LIST CONTROL (14.9 VS. 12.7, P = 0.019). TES WAS NOT ASSOCIATED WITH HADS ANXIETY REDUCTION AND HADS ANXIETY REDUCTION WAS NOT ASSOCIATED WITH CIPN PAIN REDUCTION. CONCLUSIONS: YOGA MAY REDUCE ANXIETY IN PATIENTS WITH CIPN. FUTURE STUDIES ARE NEEDED TO CONFIRM THESE FINDINGS. CLINICAL TRIAL REGISTRATION NUMBER: CLINICALTRIALS.GOV IDENTIFIER: NCT03292328.	2021	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
13 2094  42 THE EFFECT OF YOGA AND PEER SUPPORT INTERVENTIONS ON THE QUALITY OF LIFE OF WOMEN WITH DIABETES: RESULTS OF A RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: THIS WAS AN INTERVENTIONAL STUDY TO UNDERSTAND THE EFFECT OF TWO LOW-COST INTERVENTIONS; YOGA AND PEER SUPPORT ON THE QUALITY OF LIFE (QOL) OF WOMEN WITH TYPE 2 DIABETES. METHODOLOGY: AN OPEN LABEL PARALLEL THREE-ARMED RANDOMIZED CONTROL TRIAL WAS CONDUCTED AMONG 124 RECRUITED WOMEN WITH DIABETES FOR 3 MONTHS. BLOCK RANDOMIZATION WITH A BLOCK LENGTH OF SIX WAS CARRIED OUT. IN THE YOGA ARM, SESSIONS BY AN INSTRUCTOR, CONSISTING OF A GROUP OF POSTURES COORDINATED WITH BREATHING WERE CONDUCTED FOR AN HOUR, 2 DAYS A WEEK. IN THE PEER SUPPORT ARM, EACH PEER MENTOR AFTER TRAINING VISITED 13-14 WOMEN WITH DIABETES EVERY WEEK FOLLOWED BY A PHONE CALL. THE MEETING WAS ABOUT APPLYING DISEASE MANAGEMENT PLANS IN DAILY LIFE. AT THE BEGINNING AND END OF THE STUDY, QOL WAS ASSESSED BY THE TRANSLATED, VALIDATED WORLD HEALTH ORGANIZATION QOL-BREF IN FOUR DOMAINS PHYSICAL, PSYCHOLOGICAL, SOCIAL, AND ENVIRONMENTAL DOMAINS. RESULTS: THE MAJORITY (96%) OF THE STUDY PARTICIPANTS PERCEIVED THE PEER SUPPORT AND YOGA INTERVENTION TO BE BENEFICIAL. PAIRED T-TEST REVEALED SIGNIFICANT INCREASES IN THE SOCIAL AND ENVIRONMENTAL DOMAIN IN THE PEER GROUP AND IN THE ENVIRONMENTAL DOMAIN IN THE YOGA GROUP, THOUGH THIS DISAPPEARED IN THE BETWEEN-GROUP COMPARISON PERHAPS DUE TO POOR GLYCEMIC CONTROL (HEMOGLOBIN A1C VARIED FROM 9.4 TO 9.6) AND THE SHORT DURATION OF 3 MONTHS OF THE STUDY. CONCLUSION: PEER SUPPORT AND YOGA IMPROVED PERCEPTIONS OF QOL THOUGH ITS IMPACT ON SCORES WAS NOT SIGNIFICANT DUE TO A SHORT PERIOD OF STUDY AMONG WOMEN WITH POOR GLYCEMIC CONTROL.	2017	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
14  790  57 EFFECT OF YOGA EXERCISE ON THE QUALITY OF LIFE AND UPPER EXTREMITY VOLUME AMONG WOMEN WITH BREAST CANCER RELATED LYMPHEDEMA: A PILOT STUDY. PURPOSE: THIS PILOT STUDY AIMED TO EVALUATE THE EFFECT OF AN 8-WEEKS-YOGA INTERVENTION ON QUALITY OF LIFE AND UPPER EXTREMITY EDEMA VOLUME IN WOMEN WITH BREAST CANCER RELATED LYMPHEDEMA. METHODS: THIS WAS A CONTROLLED TRIAL WITH PRE-POST DESIGN. A TOTAL OF 40 WOMEN WITH BREAST CANCER RELATED LYMPHEDEMA WERE RANDOMLY ASSIGNED INTO AN INTERVENTION OR CONTROL GROUPS. THE INTERVENTION GROUP PARTICIPATED IN A YOGA EXERCISE CLASS FOR 8 WEEKS, IN A TWICE A WEEK INSTRUCTOR-LED PRACTICE AND ONCE A WEEK HOME PRACTICE. OUTCOMES WERE EORTC QLQ_C30 TO MEASURE QUALITY OF LIFE, AND WATER DISPLACEMENT VOLUME-METER TO MEASURE UPPER EXTREMITY EDEMA VOLUME. THE OUTCOMES WERE EVALUATED AT BASELINE, 4TH AND 8TH WEEK. DATA WERE ANALYZED USING SPSS. RESULTS: FOUR WEEKS AFTER THE INTERVENTION, A SIGNIFICANT DIFFERENCE WAS OBSERVED BETWEEN THE GROUPS WITH RESPECT TO ROLE FUNCTIONING OF QUALITY OF LIFE (P=0.03). EIGHT WEEKS AFTER THE INTERVENTION, A SIGNIFICANT DIFFERENCE WAS OBSERVED BETWEEN GROUPS CONCERNING PHYSICAL AND EMOTIONAL FUNCTIONING OF QUALITY OF LIFE (P<0.05). THE CHANGING TREND IN PHYSICAL, ROLE, EMOTIONAL, AND COGNITIVE FUNCTIONING HAD INCREASED, AND IN SOME SCALES SUCH AS FATIGUE, PAIN, INSOMNIA, AND FINANCIAL DIFFICULTIES THE SCORES WERE REDUCED IN THE INTERVENTION GROUP. REGARDING EDEMA VOLUME, NO SIGNIFICANT DIFFERENCE WAS FOUND BETWEEN BOTH GROUPS ON THE 4TH AND 8TH WEEK AFTER THE INTERVENTION (P>0.05). CONCLUSION: AS YOGA EXERCISE MIGHT IMPROVE PHYSICAL, ROLE, AND EMOTIONAL FUNCTIONING OF QUALITY OF LIFE AS WELL AS REDUCE FATIGUE, PAIN, AND INSOMNIA, USING THIS INTERVENTION CAN BE SUGGESTED AMONGST WOMEN WITH BREAST CANCER RELATED LYMPHEDEMA.	2019	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
15  953  55 EFFECTS OF A HEALTH WORKER-LED 3-MONTH YOGA INTERVENTION ON BLOOD PRESSURE OF HYPERTENSIVE PATIENTS: A RANDOMISED CONTROLLED MULTICENTRE TRIAL IN THE PRIMARY CARE SETTING. BACKGROUND: HYPERTENSION CONTROL REMAINS A MAJOR CHALLENGE GLOBALLY. A RECENT SYSTEMATIC REVIEW SUGGESTED THAT YOGA HAS BENEFICIAL EFFECTS ON REDUCING BLOOD PRESSURE. HOWEVER, THE ROLE OF YOGA IN HYPERTENSION MANAGEMENT IN PRIMARY HEALTH CARE HAS RECEIVED LITTLE ATTENTION, AND NO STUDIES HAVE EVALUATED THE IMPACT OF A YOGA PROGRAM FULLY DELIVERED BY HEALTH CARE STAFF ON HYPERTENSION. THIS STUDY, THEREFORE, ASSESSED THE EFFECTS OF A HEALTH WORKER-LED YOGA INTERVENTION ON BLOOD PRESSURE REDUCTION AMONG HYPERTENSIVES PATIENTS IN THE PRIMARY CARE SETTING. METHODS: THIS WAS A MULTICENTRIC, TWO-ARM, RANDOMISED TRIAL CONDUCTED AMONG HYPERTENSIVE PATIENTS IN SEVEN AYURVEDA HEALTH CENTRES IN NEPAL BETWEEN MARCH 2017 AND JUNE 2018. ONE HUNDRED AND TWENTY-ONE PARTICIPANTS WHO WERE ON OR WITHOUT MEDICATIONS WERE RANDOMISED TO INTERVENTION (N = 61) AND WAIT-LIST CONTROL (N = 60) GROUPS USING STRATIFIED BLOCK RANDOMISATION. PARTICIPANTS IN THE INTERVENTION ARM RECEIVED AN INTERVENTION CONSISTING OF AN INITIAL FIVE-DAY STRUCTURED YOGA TRAINING AT THE CENTRES AND THEN A FURTHER HOME-BASED PRACTICE OF YOGA FOR FIVE DAYS A WEEK FOR THE FOLLOWING 90 DAYS. BOTH INTERVENTION AND CONTROL GROUPS ALSO PARTICIPATED IN A 2-H HEALTH EDUCATION SESSION. THE PRIMARY OUTCOME OF THIS TRIAL WAS SYSTOLIC BLOOD PRESSURE AT 90-DAY FOLLOW-UP. DATA WERE ANALYSED ON AN INTENTION-TO-TREAT BASIS USING LINEAR MIXED-EFFECTS REGRESSION MODELS. RESULTS: WE INCLUDED ALL 121 STUDY PARTICIPANTS (INTERVENTION/CONTROL = 61/60) IN THE PRIMARY ANALYSIS (52.1% MALES; MEAN +/- SD AGE = 47.8 +/- 10.8 YEARS). THE DIFFERENCE IN SYSTOLIC BLOOD PRESSURE BETWEEN THE INTERVENTION GROUP AND THE CONTROL GROUP WAS - 7.66 MMHG (95% CI: - 10.4, - 4.93). FOR DIASTOLIC BLOOD PRESSURE, THE DIFFERENCE WAS - 3.86 MMHG (95% CI: - 6.65, - 1.06). NO ADVERSE EVENTS WERE REPORTED BY THE PARTICIPANTS. CONCLUSIONS: A YOGA PROGRAM FOR HYPERTENSIVE PATIENTS CONSISTING OF A FIVE-DAY TRAINING IN HEALTH CENTRES AND 90 DAYS OF PRACTICE AT HOME IS EFFECTIVE FOR REDUCING BLOOD PRESSURE. SIGNIFICANT BENEFITS FOR HYPERTENSIVE PATIENTS COULD BE EXPECTED IF SUCH PROGRAMMES WOULD BECOME A PART OF THE STANDARD TREATMENT PRACTICE. TRIAL REGISTRATION: THIS TRIAL WAS PROSPECTIVELY REGISTERED WITH THE CLINICAL TRIAL REGISTRY OF INDIA [ CTRI/2017/02/007822 ] ON 10/02/2017.	2021	

16  521  49 COMPARING YOGA, EXERCISE, AND A SELF-CARE BOOK FOR CHRONIC LOW BACK PAIN: A RANDOMIZED, CONTROLLED TRIAL. BACKGROUND: CHRONIC LOW BACK PAIN IS A COMMON PROBLEM THAT HAS ONLY MODESTLY EFFECTIVE TREATMENT OPTIONS. OBJECTIVE: TO DETERMINE WHETHER YOGA IS MORE EFFECTIVE THAN CONVENTIONAL THERAPEUTIC EXERCISE OR A SELF-CARE BOOK FOR PATIENTS WITH CHRONIC LOW BACK PAIN. DESIGN: RANDOMIZED, CONTROLLED TRIAL. SETTING: A NONPROFIT, INTEGRATED HEALTH CARE SYSTEM. PATIENTS: 101 ADULTS WITH CHRONIC LOW BACK PAIN. INTERVENTION: 12-WEEK SESSIONS OF YOGA OR CONVENTIONAL THERAPEUTIC EXERCISE CLASSES OR A SELF-CARE BOOK. MEASUREMENTS: PRIMARY OUTCOMES WERE BACK-RELATED FUNCTIONAL STATUS (MODIFIED 24-POINT ROLAND DISABILITY SCALE) AND "BOTHERSOMENESS" OF PAIN (11-POINT NUMERICAL SCALE). THE PRIMARY TIME POINT WAS 12 WEEKS. CLINICALLY SIGNIFICANT CHANGE WAS CONSIDERED TO BE 2.5 POINTS ON THE FUNCTIONAL STATUS SCALE AND 1.5 POINTS ON THE BOTHERSOMENESS SCALE. SECONDARY OUTCOMES WERE DAYS OF RESTRICTED ACTIVITY, GENERAL HEALTH STATUS, AND MEDICATION USE. RESULTS: AFTER ADJUSTMENT FOR BASELINE VALUES, BACK-RELATED FUNCTION IN THE YOGA GROUP WAS SUPERIOR TO THE BOOK AND EXERCISE GROUPS AT 12 WEEKS (YOGA VS. BOOK: MEAN DIFFERENCE, -3.4 [95% CI, -5.1 TO - 1.6] [P < 0.001]; YOGA VS. EXERCISE: MEAN DIFFERENCE, -1.8 [CI, -3.5 TO - 0.1] [P = 0.034]). NO SIGNIFICANT DIFFERENCES IN SYMPTOM BOTHERSOMENESS WERE FOUND BETWEEN ANY 2 GROUPS AT 12 WEEKS; AT 26 WEEKS, THE YOGA GROUP WAS SUPERIOR TO THE BOOK GROUP WITH RESPECT TO THIS MEASURE (MEAN DIFFERENCE, -2.2 [CI, -3.2 TO - 1.2]; P < 0.001). AT 26 WEEKS, BACK-RELATED FUNCTION IN THE YOGA GROUP WAS SUPERIOR TO THE BOOK GROUP (MEAN DIFFERENCE, -3.6 [CI, -5.4 TO - 1.8]; P < 0.001). LIMITATIONS: PARTICIPANTS IN THIS STUDY WERE FOLLOWED FOR ONLY 26 WEEKS AFTER RANDOMIZATION. ONLY 1 INSTRUCTOR DELIVERED EACH INTERVENTION. CONCLUSIONS: YOGA WAS MORE EFFECTIVE THAN A SELF-CARE BOOK FOR IMPROVING FUNCTION AND REDUCING CHRONIC LOW BACK PAIN, AND THE BENEFITS PERSISTED FOR AT LEAST SEVERAL MONTHS.	2005	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
17 2557  60 YOGA FOR CHRONIC CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY PAIN: A PILOT, RANDOMIZED CONTROLLED TRIAL. PURPOSE: TO DETERMINE THE FEASIBILITY OF IMPLEMENTING A YOGA INTERVENTION FOR CANCER SURVIVORS WITH CHRONIC CIPN PAIN, AS WELL AS THE IMPACT OF THE INTERVENTION ON PATIENT-REPORTED OUTCOMES. METHODS: CANCER SURVIVORS WITH CHRONIC CIPN PAIN WERE RECRUITED FROM THE BREAST, GASTROINTESTINAL, AND GYNECOLOGICAL ONCOLOGY CENTERS AT DANA-FARBER CANCER INSTITUTE. PARTICIPANTS WERE RANDOMIZED (2:1) TO RECEIVE AN 8-WEEK YOGA INTERVENTION OR USUAL CARE. AFTER 21/50 OF PARTICIPANTS WERE ENROLLED, THE COVID-19 PANDEMIC REQUIRED THE YOGA INTERVENTION TO BE DELIVERED VIRTUALLY (I.E., ZOOM). PRE- AND POST-INTERVENTION, PARTICIPANTS SELF-REPORTED CIPN AND CO-OCCURRING SYMPTOM SEVERITY. ADHERENCE TO THE INTERVENTION WAS DEFINED AS PRACTICING >/= 12 YOGA SESSIONS OVER THE 8-WEEK INTERVENTION PERIOD. CHANGES IN PATIENT-REPORTED OUTCOMES BETWEEN GROUPS WERE COMPARED USING WILCOXON'S RANK-SUM TESTS. RESULTS: PARTICIPANTS (N = 28 YOGA, N = 16 CONTROL) WERE MAINLY FEMALE (96%) AND DIAGNOSED WITH STAGE III/IV DISEASE (66%). OVERALL, 19/28 (67.8%) OF YOGA GROUP PARTICIPANTS WERE ADHERENT TO THE YOGA PROTOCOL. YOGA GROUP PARTICIPANTS EXPERIENCED SIGNIFICANT WITHIN-GROUP IMPROVEMENTS IN ALL PATIENT-REPORTED OUTCOMES, INCLUDING WORST CIPN PAIN (MEDIAN CHANGE = - 1.7, P < 0.0001) AND SENSORY CIPN (MEDIAN CHANGE = - 14.8, P < 0.0001), BUT ONLY IMPROVEMENTS IN FATIGUE (P = 0.05) AND DEPRESSION (P = 0.04) WERE SIGNIFICANT COMPARED TO THE CONTROL. THERE WERE NO DIFFERENCES (P > 0.05) IN CHANGES IN PATIENT-REPORTED OUTCOMES BETWEEN IN-PERSON (N = 6) OR VIRTUAL (N = 15) YOGA GROUP PARTICIPANTS. CONCLUSIONS: YOGA IS A FEASIBLE NON-PHARMACOLOGICAL MODALITY FOR CANCER SURVIVORS WITH CIPN, BUT MORE INFORMATION IS NEEDED REGARDING ITS IMPACT ON CIPN AND OTHER SYMPTOMS. TRIAL REGISTRATION: CLINICALTRIALS.GOV IDENTIFIER: NCT03824860 IMPLICATIONS FOR CANCER SURVIVORS: ONCOLOGY CLINICIANS MAY CONSIDER REFERRING CANCER SURVIVORS TO YOGA FOR CHRONIC CIPN PAIN, BUT YOGA CANNOT BE CURRENTLY RECOMMENDED AS AN EFFICACIOUS TREATMENT.	2021	
                                                                                                                                                                                                                                                                                                                                                                                 
18 1650  49 MULTICENTER, RANDOMIZED CONTROLLED TRIAL OF YOGA FOR SLEEP QUALITY AMONG CANCER SURVIVORS. PURPOSE: THIRTY PERCENT TO 90% OF CANCER SURVIVORS REPORT IMPAIRED SLEEP QUALITY POST-TREATMENT, WHICH CAN BE SEVERE ENOUGH TO INCREASE MORBIDITY AND MORTALITY. LIFESTYLE INTERVENTIONS, SUCH AS EXERCISE, ARE RECOMMENDED IN CONJUNCTION WITH DRUGS AND COGNITIVE BEHAVIORAL THERAPY FOR THE TREATMENT OF IMPAIRED SLEEP. PRELIMINARY EVIDENCE INDICATES THAT YOGA-A MIND-BODY PRACTICE AND FORM OF EXERCISE-MAY IMPROVE SLEEP AMONG CANCER SURVIVORS. THE PRIMARY AIM OF THIS RANDOMIZED, CONTROLLED CLINICAL TRIAL WAS TO DETERMINE THE EFFICACY OF A STANDARDIZED YOGA INTERVENTION COMPARED WITH STANDARD CARE FOR IMPROVING GLOBAL SLEEP QUALITY (PRIMARY OUTCOME) AMONG POST-TREATMENT CANCER SURVIVORS. PATIENTS AND METHODS: IN ALL, 410 SURVIVORS SUFFERING FROM MODERATE OR GREATER SLEEP DISRUPTION BETWEEN 2 AND 24 MONTHS AFTER SURGERY, CHEMOTHERAPY, AND/OR RADIATION THERAPY WERE RANDOMLY ASSIGNED TO STANDARD CARE OR STANDARD CARE PLUS THE 4-WEEK YOGA INTERVENTION. THE YOGA INTERVENTION USED THE YOGA FOR CANCER SURVIVORS (YOCAS) PROGRAM CONSISTING OF PRANAYAMA (BREATHING EXERCISES), 16 GENTLE HATHA AND RESTORATIVE YOGA ASANAS (POSTURES), AND MEDITATION. PARTICIPANTS ATTENDED TWO 75-MINUTE SESSIONS PER WEEK. SLEEP QUALITY WAS ASSESSED BY USING THE PITTSBURGH SLEEP QUALITY INDEX AND ACTIGRAPHY PRE- AND POSTINTERVENTION. RESULTS: IN ALL, 410 SURVIVORS WERE ACCRUED (96% FEMALE; MEAN AGE, 54 YEARS; 75% HAD BREAST CANCER). YOGA PARTICIPANTS DEMONSTRATED GREATER IMPROVEMENTS IN GLOBAL SLEEP QUALITY AND, SECONDARILY, SUBJECTIVE SLEEP QUALITY, DAYTIME DYSFUNCTION, WAKE AFTER SLEEP ONSET, SLEEP EFFICIENCY, AND MEDICATION USE AT POSTINTERVENTION (ALL P </= .05) COMPARED WITH STANDARD CARE PARTICIPANTS. CONCLUSION: YOGA, SPECIFICALLY THE YOCAS PROGRAM, IS A USEFUL TREATMENT FOR IMPROVING SLEEP QUALITY AND REDUCING SLEEP MEDICATION USE AMONG CANCER SURVIVORS.	2013	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
19 2415  54 YOGA AND MEDITATION FOR MENOPAUSAL SYMPTOMS IN BREAST CANCER SURVIVORS-A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: BREAST CANCER SURVIVORS HAVE ONLY VERY LIMITED TREATMENT OPTIONS FOR MENOPAUSAL SYMPTOMS. THE OBJECTIVE OF THIS TRIAL WAS TO EVALUATE THE EFFECTS OF A 12-WEEK TRADITIONAL HATHA YOGA AND MEDITATION INTERVENTION ON MENOPAUSAL SYMPTOMS IN BREAST CANCER SURVIVORS. METHODS: PATIENTS WERE RANDOMLY ASSIGNED EITHER TO A 12-WEEK YOGA AND MEDITATION INTERVENTION OR TO USUAL CARE. THE PRIMARY OUTCOME MEASURE WAS TOTAL MENOPAUSAL SYMPTOMS (MENOPAUSE RATING SCALE [MRS] TOTAL SCORE). SECONDARY OUTCOME MEASURES INCLUDED MRS SUBSCALES, QUALITY OF LIFE (FUNCTIONAL ASSESSMENT OF CANCER THERAPY-BREAST), FATIGUE (FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY-FATIGUE), DEPRESSION, AND ANXIETY (HOSPITAL ANXIETY AND DEPRESSION SCALE). OUTCOMES WERE ASSESSED AT WEEK 12 AND WEEK 24 AFTER RANDOMIZATION. RESULTS: IN TOTAL, 40 WOMEN (MEAN AGE +/- STANDARD DEVIATION, 49.2 +/- 5.9 YEARS) WERE RANDOMIZED TO YOGA (N = 19) OR TO USUAL CARE (N = 21). WOMEN IN THE YOGA GROUP REPORTED SIGNIFICANTLY LOWER TOTAL MENOPAUSAL SYMPTOMS COMPARED WITH THE USUAL CARE GROUP AT WEEK 12 (MEAN DIFFERENCE, -5.6; 95% CONFIDENCE INTERVAL, -9.2 TO -1.9; P = .004) AND AT WEEK 24 (MEAN DIFFERENCE, -4.5; 95% CONFIDENCE INTERVAL, -8.3 TO -0.7; P = .023). AT WEEK 12, THE YOGA GROUP REPORTED LESS SOMATOVEGETATIVE, PSYCHOLOGICAL, AND UROGENITAL MENOPAUSAL SYMPTOMS; LESS FATIGUE; AND IMPROVED QUALITY OF LIFE (ALL P < .05). AT WEEK 24, ALL EFFECTS PERSISTED EXCEPT FOR PSYCHOLOGICAL MENOPAUSAL SYMPTOMS. SHORT-TERM EFFECTS ON MENOPAUSAL SYMPTOMS REMAINED SIGNIFICANT WHEN ONLY WOMEN WHO WERE RECEIVING ANTIESTROGEN MEDICATION (N = 36) WERE ANALYZED. SIX MINOR ADVERSE EVENTS OCCURRED IN EACH GROUP. CONCLUSIONS: YOGA COMBINED WITH MEDITATION CAN BE CONSIDERED A SAFE AND EFFECTIVE COMPLEMENTARY INTERVENTION FOR MENOPAUSAL SYMPTOMS IN BREAST CANCER SURVIVORS. THE EFFECTS SEEM TO PERSIST FOR AT LEAST 3 MONTHS.	2015	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
20 2845  58 YOGA, EURYTHMY THERAPY AND STANDARD PHYSIOTHERAPY (YES-TRIAL) FOR PATIENTS WITH CHRONIC NON-SPECIFIC LOW BACK PAIN: A THREE-ARMED RANDOMIZED CONTROLLED TRIAL. WE AIMED TO EVALUATE THE EFFECTS OF YOGA AND EURYTHMY THERAPY COMPARED TO CONVENTIONAL PHYSIOTHERAPY EXERCISES IN PATIENTS WITH CHRONIC LOW BACK PAIN. IN A THREE-ARMED, MULTICENTRE, RANDOMIZED CONTROLLED TRIAL, PATIENTS WITH CHRONIC LOW BACK PAIN WERE TREATED FOR 8 WEEKS IN GROUP SESSIONS (75 MINUTES ONCE PER WEEK). PRIMARY OUTCOME WAS PATIENTS' PHYSICAL DISABILITY (MEASURED BY RMDQ) FROM BASELINE TO WEEK 8. SECONDARY OUTCOME VARIABLES WERE PAIN INTENSITY AND PAIN-RELATED BOTHERSOMENESS (VAS), HEALTH-RELATED QUALITY OF LIFE (SF-12) AND LIFE SATISFACTION (BMLSS). OUTCOMES WERE ASSESSED AT BASELINE, AFTER THE INTERVENTION AT 8 WEEKS AND AT A 16-WEEK FOLLOW UP. DATA OF 274 PARTICIPANTS WERE USED FOR STATISTICAL ANALYSES. THERE WERE NO SIGNIFICANT DIFFERENCES BETWEEN THE THREE GROUPS FOR THE PRIMARY AND ALL SECONDARY OUTCOMES. IN ALL GROUPS, RMDQ DECREASED COMPARABLY AT 8 WEEKS, BUT DID NOT REACH CLINICAL MEANINGFULNESS. PAIN INTENSITY AND PAIN-RELATED BOTHERSOMENESS DECREASED, WHILE QUALITY OF LIFE INCREASED IN ALL 3 GROUPS. IN EXPLORATIVE GENERAL LINEAR MODELS FOR THE SF-12'S MENTAL HEALTH COMPONENT PARTICIPANTS IN THE EURYTHMY ARM BENEFITTED SIGNIFICANTLY MORE COMPARED TO PHYSIOTHERAPY AND YOGA. FURTHERMORE, WITHIN-GROUP ANALYSES SHOWED IMPROVEMENTS OF SF-12 MENTAL SCORE FOR YOGA AND EURYTHMY THERAPY ONLY. ALL INTERVENTIONS WERE SAFE. CLINICAL TRIALS REGISTER: DRKS-ID: DRKS00004651 PERSPECTIVE: THIS ARTICLE PRESENTS THE RESULTS OF A MULTICENTRE THREE-ARMED RANDOMIZED CONTROLLED TRIAL ON THE CLINICAL EFFECTS OF THREE 8-WEEK PROGRAMS IN PATIENTS WITH CHRONIC LOW BACK PAIN. COMPARED TO THE 'GOLD STANDARD' OF CONVENTIONAL PHYSIOTHERAPEUTIC EXERCISES, EURYTHMY THERAPY AND YOGA THERAPY LEAD TO COMPARABLE SYMPTOMATIC IMPROVEMENTS IN PATIENTS WITH CHRONIC LOW BACK PAIN. HOWEVER, THE WITHIN-GROUP EFFECT SIZES WERE SMALL TO MODERATE AND DID NOT REACH CLINICAL MEANINGFULNESS ON PATIENTS' PHYSICAL DISABILITY (RMDQ).	2021